Ma et al. showed on tissue microarray and further immunohistochemistry that prostate cancer cells express high levels of CTHRC1 and that blocking CTHRC1 demonstrated inhibition of invasiveness and aggressive characteristics of the tumor and upregulation of the epithelial morphological characteristics over the mesenchymal ones [76]. This evidence concerns the gene CTHRC1 and prostate carcinoma.